BiomX Inc.
PHGE
$4.98
-$0.06-1.19%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.74M | 14.25M | 15.08M | 15.36M | 14.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.92M | 33.11M | 35.10M | 37.26M | 35.55M |
| Operating Income | -30.92M | -33.11M | -35.10M | -37.26M | -35.55M |
| Income Before Tax | -36.19M | -37.37M | -18.56M | -8.05M | -17.71M |
| Income Tax Expenses | 7.00K | 9.00K | 6.00K | 9.00K | 13.00K |
| Earnings from Continuing Operations | -36.20 | -37.38 | -18.57 | -8.06 | -17.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.20M | -37.38M | -18.57M | -8.06M | -17.73M |
| EBIT | -30.92M | -33.11M | -35.10M | -37.26M | -35.55M |
| EBITDA | -28.00M | -30.42M | -33.33M | -35.45M | -33.75M |
| EPS Basic | -22.18 | -27.35 | -15.92 | 2.26 | -33.55 |
| Normalized Basic EPS | -10.56 | -12.36 | -1.32 | 5.29 | -22.37 |
| EPS Diluted | -22.18 | -28.78 | -17.35 | -48.03 | -83.85 |
| Normalized Diluted EPS | -10.56 | -12.36 | -1.32 | 3.05 | -24.62 |
| Average Basic Shares Outstanding | 6.52M | 5.74M | 4.95M | 3.68M | 2.80M |
| Average Diluted Shares Outstanding | 6.52M | 5.74M | 4.95M | 4.10M | 3.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |